Pricing a One-Month Milk-Yield Drug for Dairy Cows: Strategy and Price Point

You are a product manager at a pharmaceutical company. Your product raises a dairy cow's milk output by 20%, and its effect lasts one month. Recommend a pricing strategy and a specific price for it. ```hint Follow the farmer's money Before choosing a pricing model, work out what one month of extra milk is actually worth to the person paying for the treatment, after anything the extra output costs them. ``` ### Clarifying Questions - Which market and type of farm do we launch to first: large commercial dairies, or smaller family and smallholder farms? - Is one dose enough for the month of effect, and does the 20% lift hold for every lactating cow or vary with breed and current yield? - Is the product approved where we launch, and are there side effects, milk withdrawal periods or buyer restrictions on milk from treated cows? - Do farmers buy directly from us, or through veterinarians and distributors who take a margin? ### What a Strong Answer Covers - A value estimate per cow per month built from labeled assumptions about yield, milk price and the extra costs of producing more milk - A comparison of pricing approaches (cost-plus, reference to alternatives, value-based) and a reasoned choice among them - A specific price with a clear split of the value between farmer and company, checked against cost, herd budgets and weaker results - How the price and offer vary by segment, market and herd size, and how the launch handles farmers' doubts about the claimed lift - Risks that limit pricing power, such as approval rules, milk buyers' policies, animal welfare and swings in milk prices ### Follow-up Questions - Milk prices fall sharply soon after launch. Do you change the price, and how? - A large dairy cooperative wants to pay only for results. Would you offer outcome-based pricing, and how would you structure it? - How would you price in a market where most farms keep a handful of cows and pay cash per treatment?